Lalach Harvey 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Jun 16, 2011
Insider Transaction Report
Form 4
Lalach Harvey
DirectorPresident CEO CFO
Transactions
- Sale
common stock
2011-06-14$2.90/sh−3,200$9,280→ 574,572 total - Sale
common stock
2011-06-15$2.81/sh−3,000$8,430→ 568,572 total - Sale
common stock
2011-06-13$3.05/sh−2,100$6,405→ 577,772 total - Sale
common stock
2011-06-15$2.84/sh−3,000$8,520→ 571,572 total
Holdings
- 579,872
common stock
- 150,000
stock options
Exercise: $3.10From: 2008-06-03Exp: 2013-06-03→ common stock (150,000 underlying) - 200,000
stock options
Exercise: $3.50From: 2010-06-29Exp: 2015-06-29→ common stock (50,000 underlying)